SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001062993-18-001559
Filing Date
2018-04-09
Accepted
2018-04-09 16:55:41
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 forms424b3.htm 424B3 1474926
2 GRAPHIC forms4x59x1.jpg GRAPHIC 5715
3 GRAPHIC forms4x59x2.jpg GRAPHIC 1723
4 GRAPHIC forms4x59x3.jpg GRAPHIC 3826
5 GRAPHIC forms4x83x1.jpg GRAPHIC 5393
6 GRAPHIC forms4x83x2.jpg GRAPHIC 5393
7 GRAPHIC forms4x84x1.jpg GRAPHIC 2477
8 GRAPHIC forms4x84x2.jpg GRAPHIC 1815
9 GRAPHIC forms4x84x3.jpg GRAPHIC 7742
  Complete submission text file 0001062993-18-001559.txt   1524121
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B3 | Act: 33 | File No.: 333-222451 | Film No.: 18746134
SIC: 1000 Metal Mining
Office of Energy & Transportation